Images that “mirror the demographic profile of their target audience” perform best, according to an eye-tracking study from picture provider Shutterstock.
Nearly every $100,000 drug approved in the last three years was for a rare disease
This includes Sarepta Therapeutics’ Exondys 5 and Vertex Pharmaceuticals’ Orkambi.
Infographic: The battle for medication adherence
May 15, 2017
8:35 pm
Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.
Study: One-third of new drugs report safety issues
An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.